Delix Therapeutics Appoints Aaron Koenig, Md As Chief Medical Officer

Jun 12, 2023•about 2 years ago

Position

Chief Medical Officer

Company

Delix Therapeutics

Aaron Koenig

BostonBiotechnologyScience And EngineeringData And AnalyticsHealth Care

Description

Delix Therapeutics , a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the appointment of Dr. Aaron Koenig as Chief Medical Officer. Dr

Company Information

Company

Delix Therapeutics

Location

Boston, Massachusetts, United States

About

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months